Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · Real-Time Price · USD
4.470
-0.130 (-2.83%)
At close: Dec 8, 2025, 4:00 PM EST
4.458
-0.012 (-0.27%)
After-hours: Dec 8, 2025, 5:55 PM EST
Aurora Cannabis Employees
Aurora Cannabis had 1,073 employees as of March 31, 2024. The number of employees decreased by 57 or -5.04% compared to the previous year.
Employees
1,073
Change (1Y)
-57
Growth (1Y)
-5.04%
Revenue / Employee
$245,639
Profits / Employee
-$38,312
Market Cap
261.37M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 1,073 | -57 | -5.04% |
| Mar 31, 2023 | 1,130 | -208 | -15.55% |
| Jun 30, 2022 | 1,338 | -423 | -24.02% |
| Jun 30, 2021 | 1,761 | -970 | -35.52% |
| Jun 30, 2020 | 2,731 | -48 | -1.73% |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ACB News
- 11 hours ago - Aurora Names Seasoned Global CPG Executive to Lead Australia and New Zealand - PRNewsWire
- 6 days ago - Aurora Announces Distribution Partnership with Leafio Australia - PRNewsWire
- 24 days ago - 3 Of The Best Marijuana Stocks To Buy For Possible Gains In 2026 - MarijuanaStocks
- 4 weeks ago - Aurora Cannabis: Upgrading On High-Margin Medical Cannabis Sales Growth - Buy - Seeking Alpha
- 4 weeks ago - Aurora Cannabis Inc. (ACB:CA) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Aurora Cannabis Announces Fiscal 2026 Second Quarter Results - PRNewsWire
- 4 weeks ago - Top Canadian Cannabis Stocks to Watch in November 2025 - MarijuanaStocks
- 5 weeks ago - 'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance - CNBC